Insider Trading History of Bryan Jones W.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Bryan Jones W. since 2015. The trader's CIK number is 1540660. At the time of the last reporting, Bryan Jones W. was the VP of Business Development of Sucampo Pharmaceuticals, Inc.. (stock ticker symbol SCMP). Also see all insider trading activities at Sucampo Pharmaceuticals, Inc..

Note that in the past Bryan Jones W. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Sucampo Pharmaceuticals, Inc. (SCMP) by Bryan Jones W.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 SCMP 4,700 $49,820 0 $0 0 $0

Yearly summary of insider trading at Supernus Pharmaceuticals, Inc. (SUPN) by Bryan Jones W.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 SUPN 0 $0 8,612 $103,444 8,612 $22,806


Insider trading activities at 2 companies by Bryan Jones W.:

1. Sucampo Pharmaceuticals, Inc. (SCMP)

2. Supernus Pharmaceuticals, Inc. (SUPN)

Table 1. Insider trading of Sucampo Pharmaceuticals, Inc. (SCMP) by Bryan Jones W.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-08-04 SCMP Buy 4,700 10.60 49,820

Table 2. Insider trading of Supernus Pharmaceuticals, Inc. (SUPN) by Bryan Jones W.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-03-30 SUPN Sale 6,712 12.02 80,644
2015-03-30 SUPN Option Ex 6,712 2.56 17,182
2015-03-24 SUPN Option Ex 1,900 2.96 5,624
2015-03-24 SUPN Sale 1,900 12.00 22,800

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bryan Jones W. (VP of Business Development of Sucampo Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.